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Abstract
To eliminate and eradicate gambiense human African trypanosomiasis (HAT), maximizing
the effectiveness of active case finding is of key importance. The progression of the epi-
demic is largely influenced by the planning of these operations. This paper introduces and
analyzes five models for predicting HAT prevalence in a given village based on past
observed prevalence levels and past screening activities in that village. Based on the quality
of prevalence level predictions in 143 villages in Kwamouth (DRC), and based on the theo-
retical foundation underlying the models, we consider variants of the Logistic Model—a
model inspired by the SIS epidemic model—to be most suitable for predicting HAT preva-
lence levels. Furthermore, we demonstrate the applicability of this model to predict the
effects of planning policies for screening operations. Our analysis yields an analytical
expression for the screening frequency required to reach eradication (zero prevalence) and
a simple approach for determining the frequency required to reach elimination within a
given time frame (one case per 10000). Furthermore, the model predictions suggest that
annual screening is only expected to lead to eradication if at least half of the cases are
detected during the screening rounds. This paper extends knowledge on control strategies
for HAT and serves as a basis for further modeling and optimization studies.
Author Summary
The primary strategy to fight gambiense human African trypanosomiasis (HAT) is to per-
form extensive population screening operations among endemic villages. Since the pro-
gression of the epidemic is largely influenced by the planning of these operations, it is
crucial to develop adequate models on this relation and to employ these for the develop-
ment of effective planning policies. We introduce and test five models that describe the
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expected development of the HAT prevalence in a given village based on historical infor-
mation. Next, we demonstrate the applicability of one of these models to evaluate planning
policies, presenting mathematical expressions for the relationship between participation in
screening rounds, sensitivity of the diagnostic test, endemicity level in the village consid-
ered, and the screening frequency required to reach eradication (zero prevalence) or elimi-
nation (one case per 10000) within a given time-frame. Applying these expressions to the
Kwamouth health zone (DRC) yields estimates of the maximum screening interval that
leads to eradication, the expected time to elimination, and the case detection fraction
needed to reach elimination within five years. This paper serves as a basis for further
modeling and optimization studies.
Introduction
Human African trypanosomiasis (HAT), also known as sleeping sickness, is a parasitic disease
that is caused by two sub-species of the protozoa Trypanosoma brucei: Trypanosoma brucei
gambiense (gambiense HAT) and Trypanosoma brucei rhodesiense (rhodiense HAT). The
infection causing the disease is transmitted from person to person through the tsetse fly. It is
estimated that there were 20000 cases in the year 2012 [1] and that 70 million people from 36
Sub-Saharan countries are at risk of HAT infection [2, 3].
Our work focuses on gambiense HAT, which represents 98% of all HAT cases [3]. Gam-
biense HAT, which we will refer to as “HAT” from now on, is a slowly progressing disease and
is fatal if left untreated. In the first stage of the disease, symptoms are usually absent or non-spe-
cific [4]. The median duration of this stage is about 1.5 years [5]. By the time patients arrive at a
healthcare provider, the disease has often progressed to the neurological phase, which causes
severe health problems. In addition, this treatment delay increases the rate of transmission,
since an infected patient is a potential source of infection for the tsetse fly [4, 6]. Therefore,
active case finding and early treatment are key to the success of gambiense HAT control [7, 8].
The current case finding strategy uses mobile teams that travel from village to village to con-
duct exhaustive population screening [4, 8, 9]. For example, 35 mobile teams are active in the
Democratic Republic of the Congo (DRC). Because this strategy has considerably reduced dis-
ease prevalence in several African countries [6, 10–12], the disease is no longer perceived as a
major threat. Consequently, donors are now scaling down their financial commitments [8].
This, however, poses a serious risk to the control of HAT. The disease tends to re-emerge when
screening activities are scaled down, bringing about the risk of a serious outbreak, as shown by
an epidemic in the 1990s [4, 11, 13]. For example, the number of cases in 1998 is estimated to
have exceeded 300000 [3].
In order to minimize the risk of re-emergence when resources are scaled down, and in order
to eliminate and eradicate the disease, maximizing the effectiveness of the control programs is
crucial. Mpanya et al. [9] suggest that the effectiveness of population screening is determined
by (among others) the management and planning of the mobile teams. Planning decisions—
which determine which villages to screen, and at what time interval to screen them—have a
direct impact on the risk and the magnitude of an outbreak. Existing literature does not address
these issues, as highlighted by the WHO [1], and a wide variety of screening intervals have
been applied in different control programs [12, 14, 15]. To optimize the planning decisions, it
is of key importance to be able to predict the evolution of the HAT prevalence level in the vil-
lages at risk. This allows decision makers to assess the relative effectiveness of a screening
round in these villages and to prioritize the screening rounds to be performed.
Forecasting HAT Prevalences
PLOS Computational Biology | DOI:10.1371/journal.pcbi.1005103 September 22, 2016 2 / 23
However, practical tools for predicting HAT prevalence appear to be lacking. Existing mod-
els for HAT are mostly based on differential equations, describing the rate of change for the
HAT prevalence level among humans and flies as a function of the prevalence levels among
humans and flies (some models also include an animal reservoir) [16–22]. As the information
needed to use such models—e.g., the number of tsetse flies in a village—is not available on the
village level, using these models for prediction is impractical.
This paper therefore sets out to develop practical models describing and predicting the
expected evolution of the HAT prevalence level in a given village, based on historical informa-
tion on HAT cases and screening rounds in that village. The main difference with the models
mentioned in the previous paragraph is that our models make no assumptions about the causal
factors underlying the observed prevalence levels: the “inflow” of newly infected persons and
the “outflow” of infected persons by cure or death. Instead, we just consider data on the net
effect of these two processes—the evolution of the prevalence level—and fit five different mod-
els to this. To analyze the predictive performance of these models, we make use of a dataset
describing screening operations and HAT cases in the Kwamouth district in the DRC for the
period 2004–2013.
Furthermore, we use one of the models to analyze the fixed frequency screening policy, which
assigns to each village a fixed time interval for consecutive screening rounds. Specifically, we
investigate screening frequency requirements for reaching elimination and eradication. Here,
eradication is defined as “letting the expected prevalence level go to zero in the long term”, and
elimination is defined as “reaching an expected prevalence level of one case per 10000”.
Our paper thereby contributes to the branch of research on control strategies for HAT.
Next, we list several other papers that are highly related to our work. The effectiveness of active
case finding operations is analyzed by Robays et al. [23], who define “effectiveness” as the
expected fraction of cases in a village which will eventually get cured as a result of a screening
round in that village. The papers by Stone & Chitnis [16], Chalvet-Monfray et al. [20], and
Artzrouni & Gouteux [24] introduce differential equation models to gain structural insights on
the effectiveness of combinations of active case finding and vector control efforts and on the
requirements for eradicating HAT. The effect of active case finding activities is modeled
through a continuous “flow” of infected individuals into the susceptible compartment. Since
we explicitly model the timing and the effects of a screening round, this is one of the main dif-
ferences with our paper. Finally, Rock et al. [10] study the effectiveness of screening and treat-
ment programs and the time to elimination using a multi-host simulation model. Their paper,
however, considers the screening frequency as a given, whereas we consider the effects of
changing this frequency. Furthermore, we propose models for predicting prevalence on a vil-
lage level, whereas their model implicitly assumes all villages to be homogeneous.
Materials and Methods
Data
Our dataset consists of information on screening operations in the period 2004–2013 in the
health zone Kwamouth in the province Bandundu. The raw data were cleaned up based on the
rules described in S1 Text. The number of villages in the dataset equals 2324, and 143 of these
villages were included in the data analysis based on three criteria: (1) the number of screening
rounds recorded was at least two, (2) at least one case has been detected over the time horizon,
and (3) at least one record of the number of people screened during the operation was available.
The first condition is necessary to enable modeling the prevalence level observed in a given
screening round as a function of past observed prevalence levels, and the third condition is nec-
essary for estimating prevalence itself. We estimate the prevalence level in a village at the time
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of a screening round as the number of cases detected in that round over the number of people
participating in that round. Furthermore, lacking population size data, we estimate the popula-
tion of a village as the maximum number of people participating in a screening round reported
for that village. Though our dataset also contains cases identified by the regular health system
in between successive screening rounds, these do not yield (direct) estimates of prevalence lev-
els in the corresponding villages, as required by the models proposed in the next section. We
therefore focus on the active case finding data only.
The total number of screening rounds reported for the 143 villages included equals 766 (on
average 5.4 per village). Fig 1 shows cumulative distributions of the observed prevalence level
in these screening rounds (mean 0.0055, median 0.0011, standard deviation 0.0121), the time
interval between each pair of consecutive screening rounds (mean 1.28, median 1.00, standard
deviation 1.03), the estimated population for each village (mean 1073, median 450, standard
Fig 1. Descriptive statistics of the dataset.
doi:10.1371/journal.pcbi.1005103.g001
Forecasting HAT Prevalences
PLOS Computational Biology | DOI:10.1371/journal.pcbi.1005103 September 22, 2016 4 / 23
deviation 2046), and the participation level in the screening rounds (mean 0.69, median 0.72,
standard deviation 0.27). Note that the relatively large number of observations with a participa-
tion level of 100% is due to the method used to estimate the population sizes.
Prediction Methods
Before we propose our prediction methods, we introduce some notations. A table of the most
important notations used in this article can be found in S1 Table. Let sv = {sv1, sv2, . . .} denote
the vector of screening time intervals for village v, where sv1 denotes the time between the start
of the time horizon and the first screening for this village, sv2 denotes the time between the first
and the second screening, and so on. The time at which the nth screening is performed is given
by Svn = ∑mn svm and the participation fraction in this screening round is denoted by pvn.
Parameter Nv represents the population size of village v. Furthermore, let iv represent historical
information on HAT cases in this village: the numbers of cases detected during past screening
rounds. We model the expected prevalence level at time t in village v as a function fv() of sv, iv,
and some parameters β: fv(t, sv, iv, β). Note that the expected prevalence level is a latent, i.e.
unobserved, variable, and that the observed prevalence level, xv(t), generally deviates from the
expected value. We measure prevalence levels fv() and xv() as fractions and represent the differ-
ence between the expected and observed prevalence level in village v by the random variable εv:
xvðtÞ ¼ fvðt; sv; iv; bÞ þ εv ð1Þ
Time series models such as discrete time ARMA, ARIMA or ARIMAXmodels seem to be
the most popular methods for predicting prevalence (or incidence) (see e.g. [25, 26]). These
models describe the prevalence level at time t as a linear function of the prevalence levels at time
t − 1, t − 2, . . . and (optionally) some other variables. Their applicability in our context is how-
ever limited. Discrete time models require estimates of the prevalence level at each time unit
(e.g., each month), whereas information to estimate the HAT prevalence level is available only
at moments at which a screening round is performed. Namely, many HAT patients are not
detected by the regular health system, particularly if they are in the first stage of the disease [8].
The class of continuous time models is much more suitable for analyzing data observed at
irregularly spaced times. These models assume that the variable of interest, fv(t, sv, iv, β), follows
a continuous process, defining its value at each t> 0. The next subsections propose five contin-
uous time models for predicting HAT prevalence levels. We again note that models describing
the causal processes determining the observed prevalence levels in detail (e.g., by explicitly
modelling disease incidence, passive case finding, death and cure) may be most intuitive, but
require data that are not available on a village level. Therefore, to safeguard their relevance for
practical application, the variables we include are only those that are available on a large scale.
This does not imply that our models neglect the causal processes. Instead, they are to some
extent accounted for in an implicit way by fitting the models to the observed prevalence levels.
Data that are typically available at village level are numbers of HAT cases found during
screening rounds and the times of these screening rounds. For a given village, the first yields
estimates of past prevalence levels, and the latter yield the time intervals between past screening
rounds. We hypothesize that the current expected prevalence level at time t is related to past
prevalence levels, past screening intervals, and in particular the time since the last screening
round, which we denote by dv ðtÞ ¼ min nft  SvnjSvn  tg. Hence, we include (functions of)
these variables in our models.
Linear regression models are very widely used in the world of forecasting (see e.g. [27]).
Major advantages of these models are that they are easy to understand, to implement, to fit,
and to analyze. Therefore, the first model we introduce is a linear model (model 1), which also
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serves as a benchmark for our more advanced models. This model describes the expected HAT
prevalence in a given village as a function of the time since the last screening and past preva-
lence levels. Such linear model is, however, very vulnerable to a typical structure present in
active case finding datasets. High past prevalence levels tend to increase the priority of screen-
ing a village, causing the time intervals between screening rounds to decrease. As a result, dv ðtÞ
is a highly “endogenous” variable. More formally, external variables (past prevalence levels) are
correlated with both the dependent variable (fv(t)) and the independent variable (d

v ðtÞ), which
makes it hard to quantify the (causal) relation between them. In response to this, we present
four alternative models. Model 2 is a ﬁxed effects model, which adds a dummy-variable for
each village to the initial model. Model 3 is a (non-linear) exponential growth and decay model
which is inspired by the SIS epidemic model. This model is being used extensively for modeling
epidemics that are characterized by an initial phase in which the number of infected individuals
grows exponentially, and a second phase in which this number levels off to a time-invariant
carrying capacity. We refer to model 3 as the logistic model with a constant carrying capacity.
Finally, model 4 is a less data dependent version of model 3 and model 5 is variant of model 3
in which the carrying capacity is allowed to vary over time.
Model 1: Linear Model. Let xv(Svn) and xvðSvnÞ represent the observed prevalence level
exactly at the nth screening round in village v and the average observed prevalence level in the
three years prior to the nth screening round in village v, respectively. (For screening rounds in
the ﬁrst T< 3 years of our dataset, xvðSvnÞ represents the average prevalence levels in these T
years). The linear model (LM) describes the expected prevalence level at time t, fvðSvn þ dv ðtÞÞ
as a function of the time since the last screening round in village v before time t, and past
observed prevalence levels in that village:
xvðSvn þ dv ðtÞÞ ¼ fvðSvn þ dv ðtÞÞ þ εv
¼ b1xvðSvnÞ þ b2xvðSvnÞ þ b3
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
dv ðtÞ
p þ b4dv ðtÞ þ b5xvðSvnÞ ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃdv ðtÞp
þ b6xvðSvnÞ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
dv ðtÞ
p þ b7xvðSvnÞdv ðtÞ þ b8xvðSvnÞdv ðtÞ þ εv
ð2Þ
We include the term
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
dv ðtÞ
p
into this model to incorporate the non-linear nature that char-
acterizes epidemics: the (increase in the) number of cases typically levels off after an initial
phase of fast growth. Furthermore, we include the cross terms based on the hypothesis that the
prevalence level increases faster over time for villages which have higher past prevalence levels.
Model 2: Fixed Effects Model. Datasets about the HAT epidemic, such as the data set
used in this study, show much similarity to panel data in the sense that both our data and
panel data consist of observations at multiple points in time for multiple units (i.e., villages).
The causality problem mentioned in the introduction of this section can be regarded as the
problem that differences between units explain part of the regressors. A common way to deal
with differences between units in panel data is to assume that there is a unit-specific, time-
invariant fixed effect that contributes to the dependent variable. This is modeled by adding a
constant for each unit to the regression model. Thereby, the model relates deviations from the
fixed effect to variations in the explanatory variables. In line with this, we consider the follow-
ing regression model, which we denote by the fixed effects model (FEM):
xvðSvn þ dv ðtÞÞ ¼ fvðSvn þ dv ðtÞÞ þ εv
¼ av þ b1xvðSvnÞ þ b2xvðSvnÞ þ b3
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
dv ðtÞ
p þ b4dv ðtÞ
þ b5xvðSvnÞ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
dv ðtÞ
p þ b6xvðSvnÞ ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃdv ðtÞp þ b7xvðSvnÞdv ðtÞ
þ b8xvðSvnÞdv ðtÞ þ εv
ð3Þ
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Here, αv represents the fixed effect for village v. Note that the term αv forms the only differ-
ence between the FEM and the linear model.
Model 3: Logistic Model with a Constant Carrying Capacity. Literature suggests that the
development of the expected fraction of individuals infected with HAT grows exponentially in
a first phase and that this fraction levels off to (or oscillates around and converges to) an equi-
librium prevalence level in a second phase [21, 22]. We refer to the equilibrium prevalence
level as the carrying capacity. A simple epidemic model that incorporates these effects is the SIS
model, which describes the evolution of the expected prevalence level in village v by means of
the following differential equation:
dfvðtÞ
dt
¼ k  fvðtÞ 1
fvðtÞ
Kv
 
ð4Þ
Here, as in the previous section, fv(t) denotes the expected fraction of people in population v
who are infected at time t, Kv represents the carrying capacity of this village, and κ represents a
parameter indicating the speed of convergence to the epidemic equilibrium. When the epi-
demic is in its initial phase, the growth rate of fv(t) is approximately κ  fv(t), whereas this rate
goes to 0 when fv(t) approaches the carrying capacity Kv. We propose to use the explicit solu-
tion to this differential equation to model the development of the expected HAT prevalence
level in village v. This solution is obtained by multiplying both sides of Eq (4) by dt, taking the
integral on both sides, and regarding the previous screening (i.e., the one performed at time
Svn) as the beginning of the time horizon:
fvðSvn þ dv ðtÞÞ ¼
Kv
1þ Avn  ekdv ðtÞ
ð5Þ
Avn can be interpreted as a parameter determining the expected prevalence level immediately
after the nth screening round in village v: Avn ¼ KvfvðSþvnÞ  1, where S
þ
vn denotes this moment.
We fit the parameters in function (5) using the dataset described in the previous section. To
keep the model simple, we assume that κ is constant over time and over villages (i.e., this
parameter is an intrinsic property of the epidemic). Furthermore, we specify an interval of real-
istic values for κ based on the following reasoning. Note that κ represents the expected number
of new infections per infected person per time unit in a population that is almost completely
susceptible: fv(t)! 0. Now let r represent the yearly removal rate for HAT—the rate of pro-
gression to death or cure—and let R0 denote the basic reproduction number for HAT—the
average number of secondary cases induced by one case in an otherwise susceptible population.
Since the expected disease duration of this one case is 1
r
years, the average rate at which second-
ary infections are induced by this one case equals R01
r
¼ r  R0 per year. Under the assumption
that this rate is constant over the disease duration, this implies that κ = r  R0. Since several
analyses suggest that the value of R0 is generally close to 1 in endemic regions [10, 17, 29], we
hypothesize that R0 2 [1.0, 1.5]. Furthermore, 95% conﬁdence intervals for the stage 1 and
stage 2 disease duration, as presented by Checchi et al. [5], suggest that r lies in the interval
[0.22, 0.52]. Based on these ranges we estimate that κ lies in the interval [0.2, 0.8]. We note that
one could try to estimate village-speciﬁc or focus-speciﬁc ranges for R0 (and hence for κ) using
the next-generation matrix method, as proposed by [28]. Yet, as the corresponding data
requirements are relatively large, we deem this to be practically unsuitable.
Furthermore, we hypothesize that Kv is highly related to past prevalence levels and past
screening activities in village v. Higher prevalence levels indicate a higher carrying capacity.
Furthermore, if two villages had equal prevalence levels, but if village 1 has been screened more
frequently than village 2, this may indicate that the carrying capacity in village 1 is higher. In
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accordance with these hypotheses, we estimate Kv as:
Kv ¼ b1 þ b2~mv~xv ð6Þ
Here, ~xv and ~mv denote the observed average prevalence level in village v during ﬁve conse-
cutive years and the average screening frequency (screening rounds per year) in this village
during these years, respectively. We take the last ﬁve years of data in our estimation sample (as
we discuss in the next section, we split up the dataset in an estimation sample and a prediction
sample). If only T< 5 years of data are available, we base ~xv and ~mv on these T years. Note that
variables ~xv and ~mv are based on historical information and hence that these variables (and
hence the estimated carrying capacity) are not affected by current screening frequency deci-
sions. Furthermore, we note that these variables should be based on the same period of ﬁve
years, since combined information on the screening efforts and resulting prevalence levels pro-
vides insight into the epidemic potential in a village.
The estimate of Kv provides one of the two inputs for determining Avn. The second input is
the expected prevalence level in village v at time Sþvn (i.e., immediately after the n
th screening
round). Under the assumption that infected individuals who are detected during a screening
round are immediately “removed”, the only people infected at time Sþvn are those who did not
participate in the screening round and those not detected by the diagnostic test. This suggests
the following relation between the expected prevalence after and the expected prevalence
before the nth screening round in village v:
fvðSþvnÞ ¼ 1 pvn  sð ÞfvðSvnÞ ð7Þ
Here, pvn and s denote the participation in the n
th screening in village v and the sensitivity of
the diagnostic test, and Svn denotes the moment right before the infected individuals were
removed. We assume that s = 0.925 based on the review by Brun et al. [4], and obtain the fol-
lowing estimator for Avn:
Avn ¼
Kv
fvðSþvnÞ
 1 ¼ b1 þ b2~mv~xvð1 pvn  sÞfvðSvnÞ
 1 ð8Þ
The model requires an assumption about the (unobserved) expected prevalence level at the
beginning of the time horizon (i.e., at 01-01-2004). The only information we have about this
level is that it is lower than the expected prevalence level at the first screening round. Further-
more, under the realistic assumption that the epidemic is in its “convex part”, the expected
prevalence level will have steeply increased between 01-01-2004 and the first screening
round, suggesting that there is a substantial difference between the two. Therefore, taking ~xv
as an estimate of the expected prevalence level at the ﬁrst screening round and lacking further
information, we choose to estimate fv(0) as half the average observed prevalence level during
ﬁve years: 0:5~xv . The section Comparison of Models discusses the sensitivity of our results
with respect to this choice.
Substituting Eqs (6) and (8) into the definition of the prevalence level Eq (5) we obtain the
following model, which we refer to as the Logistic Model with a Constant Carrying Capacity
(LMCCC), and which we fit by estimating the parameters κ, β1, and β2:
xvðSvn þ dv ðtÞÞ ¼ fvðSvn þ dv ðtÞÞ þ εv
¼ b1 þ b2~mv~xv
1þ b1 þ b2~mv~xvð1 pvn  sÞfvðSvnÞ
 1
 
 ekdv ðtÞ
þ εv ð9Þ
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Note that the expected prevalence level before the nth screening round, fvðSvnÞ, depends on
the estimated values of κ, β1, and β2. In fact, by substituting its deﬁnition, Eq (9) can be written
in the following form (see S2 Text):
xvðSvn þ dv ðtÞÞ ¼
b1 þ b2~mv~xv
1þPinaviekdvi þ εv ð10Þ
Here, avi and δvi denote some nonnegative constants.
Model 4: Restricted Logistic Model with a Constant Carrying Capacity. Estimates of
historical prevalence levels ~xv are available on a very large scale. The national HAT control pro-
grams are a main source of these data, as they keep track of all HAT cases found. Alternatively,
modeling studies have yielded estimates of the incidence levels in Sub-Saharan Africa at the
level of detail of 1 km2 (see [2, 30]), which can be transformed into corresponding estimates of
prevalence levels. Data to measure ~mv, the historical screening frequency in village v, are how-
ever scarcer in general, as gathering these data brings about a signiﬁcant administrative burden.
It is therefore relevant to investigate the predictive performance of a model that only uses ~xv to
estimate Kv instead of ~mv~xv. We do so by ﬁtting the following model, which we refer to as the
restricted Logistic Model with a Constant Carrying Capacity (rLMCCC):
xvðSvn þ dv ðtÞÞ ¼
b1 þ b2~xv
1þ b1þb2~xvð1pvn sÞfvðSvnÞ  1
 
 ekdv ðtÞ
þ εv ð11Þ
Model 5: Logistic Model with a Varying Carrying Capacity. The models presented in the
previous subsections implicitly assume that the carrying capacity (i.e., the upper bound on the
expected prevalence level) remains the same over time. However, due to possible changes in
conditions that affect the disease dynamics—such as vegetation, the number of flies and
humans in and around a village, passive case finding activities—it is realistic to assume that the
carrying capacity may vary over time. Furthermore, the epidemic potential may also vary due
to variations in susceptibility to or tolerance of HAT infection, as argued by Welburn et al.
[31]. Based on this assumption, we propose a Logistic Model with a Varying Carrying Capacity
(LMVCC):
xvðSvn þ dv ðtÞÞ ¼
b1 þ b2mvðSvnÞxvðSvnÞ
1þ b1þb2 mvðSvnÞxvðSvnÞð1pvn sÞfvðSvnÞ  1
 
 ekdv ðtÞ
þ εv ð12Þ
The only change with respect to the logistic model with a constant carrying capacity is that
~xv and ~mv are replaced by xvðSvnÞ and mvðSvnÞ, the average observed prevalence level in and the
screening frequency for village v in the three years prior to the nth screening round in that vil-
lage, respectively.
Model Fitting
As HAT prevalence levels are very low, the variance of these levels is high, which enhances the
chance that there are significant outliers among the observations. For example, no cases were
detected in three out of four screening rounds performed in a village of 122 people, whereas
five cases were detected in the 4th round. This implies two things. First, observed prevalence
levels will generally deviate significantly from expected prevalence levels. Second, we need to
choose a technique for estimating the model coefficients that is robust with respect to outliers.
Instead of Least Squares (LS) regression, one of the most commonly applied model fitting
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methods, we therefore use Least Absolute Deviations (LAD) regression to fit the model param-
eters, which is known to be relatively insensitive to outlying observations [32]. An alternative
technique would be to use a maximum likelihood estimation (MLE) approach based on a
heavy-tailed probability distribution for the observed prevalence levels. In S2 Table, we show
the results obtained when assuming a Poisson, Beta-Binomial, or Negative Binomial distribu-
tion. Each of the MLE approaches is, however, clearly outperformed by the LAD regression
approach.
The variance of the observed prevalence level strongly depends on the sample size. For
example, under the assumption of an independent infection probability for each person, the
variance is inversely proportional to the sample size. We therefore weight the fitting deviation
evn = fv(Svn) − xv(Svn) for observation n for village v by weight wvn ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Nv  pvn
p
, yielding the fol-
lowing weighted LAD regression problem:
min
b
SabsðbÞ ¼
X
ðv;nÞ
wvnjevnj ð13Þ
To deal with the risk of overfitting, we select the variables to be included in the models by
means of a backward elimination method. This method initially includes all variables in the
model and iteratively removes the least significant variable (if its p-value> 0.10) and estimates
the model with the remaining variables. The algorithm stops as soon as all remaining variables
are significant or if only one variable is left. We enforce that αv and κ cannot be removed by
the backward elimination method so as to preserve essential elements of the corresponding
models. Hence, only parameters β1-β8 in models 1 and 2, and parameters β1-β2 in models 3–5
could be removed.
Finally, to test the predictive performance of the models, we split the data in an estimation
sample (which we use for fitting the model) and a prediction sample. Specifically, for each of the
143 villages, we include the last screening round in the prediction sample, and include the others
in the estimation sample. Next, we measure performance based on the mean of the prediction
errorsME ¼
P
v
e^vn
jVj , indicating whether the predictions obtained by the model are biased, and
based on two indicators for the amount of explained variation in the prevalence levels: the mean
absolute error,MAE ¼
P
v
je^vn j
jVj and the mean relative error,MRE ¼
P
v
je^vn jP
v
xvðS^vn Þ
. Here, the index
combination^ vn indicates the last screening round for village v. The intuition behind the mea-
sures of explained variation is that they equal 0 if the predicted prevalence levels are exactly
equal to the observed prevalence levels (i.e., the model perfectly explains the variation in the
observed prevalence levels) and that their value increases when the absolute difference between
predicted and observed levels increases (i.e. when the model explains less variation in observed
prevalence levels). We use Matlab R2015b for the implementation of our methods.
Results
Fitted Models
Table 1 presents the coefficient estimates for the variables of the five presented models. The
results for models 1 and 2 are very similar. Seven of the eight variables are identified as being
non-significant by the backward elimination algorithm: the interaction terms, the long term
prevalence level, the time since the last screening round, and the square root of the time since
the last screening round. The resulting model provides a clear prediction method: the expected
prevalence equals 24.5% of the prevalence level observed at the previous screening round
(note, if this level was 0.0%, the estimated expected prevalence remains 0.0%) according to
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model 1, and equals 14.7% of this prevalence level plus a constant fraction αv according to
model 2. Hence, this model predicts that, in the absence of screening activities, the expected
prevalence remains the same over time.
The fitted models 3, 4, and 5 reveal a clear and intuitive relationship between screening fre-
quency, prevalence, and carrying capacity: a larger historical prevalence indicates a higher carry-
ing capacity, and facing an equal historical prevalence for a higher historical screening frequency
indicates a higher carrying capacity. The constant term has been identified as non-significant for
models 3 and 4 and as significant for model 5. To illustrate the typical output of models 3 and 4,
Fig 2 shows the development of the expected prevalence levels for two villages over time (the
lines), as well as the observed prevalence levels (stars and circles). Furthermore, Fig 3 depicts the
carrying capacities for the 143 villages in Kwamouth, as estimated by the LMCCCmodel.
Though data to validate these estimates are lacking, we note that they are in the same order of
magnitude as prevalence levels found during screening rounds. The latter are usually between 1%
and 5% in high or very high transmission areas, and exceed 10% in some extreme cases [33, 34].
Comparison of Models
As mentioned in Section Model Fitting, we measure the predictive performance of the different
models in terms of the prediction bias and in terms of the amount of variation explained.
Table 2 contains the values of the different indicators for each of the models, and Fig 4 and S1
Fig. compare the prediction errors produced by the different models. These prompt several
interesting observations.
First, the prediction bias ranges from 0.47/1000 (rLMCCCmodel) to -1.86/1000 (LM
model). Given that the average observed prevalence in the 766 screening rounds in our dataset
equals 5.5/1000, we consider the biases of the LMmodel and the LMVCCmodel as quite sub-
stantial. Yet, this may be very well explained by the highly variable character of the HAT epi-
demic. A small number of outbreaks may substantially shift the average observed prevalence
level. For example, without the four most negative prediction errors, the prediction bias for the
LMmodel would be only -0.69/1000.
Table 1. Estimated weighted LAD regression models.
Variable Coefﬁcient name Coefﬁcient value Std error P-value
Model 1: Linear Model
xv(Svn) β2 0.245 0.035 0.000
Model 2: Fixed Effects Model*
xv(Svn) β2 0.147 0.055 0.004
Model 3: Logistic Model with a Constant Carrying Capacity
~mv~xv β2 1.763 0.409 0.000
dv ðtÞ κ 0.800 0.086 0.000
Model 4: Restricted Logistic Model with a Constant Carrying Capacity
~xv β2 1.234 2.210 0.288
dv ðtÞ κ 0.800 0.130 0.000
Model 5: Logistic Model with a Varying Carrying Capacity
Constant β1 0.004 0.001 0.002
mvðSvnÞxvðSvnÞ β2 0.330 0.157 0.018
dv ðtÞ κ 0.800 0.123 0.000
* For sake of conciseness, the estimates of αv are not given here.
doi:10.1371/journal.pcbi.1005103.t001
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Second, the LMmodel performs relatively well in terms of explained variation. Yet, we see
two vulnerabilities of this model: (1) as discussed before, this model is likely to be hampered by
endogeneity, inducing a potential bias in the coefficient estimates, and (2) the variation in the
screening intervals is relatively small for the villages with the highest endemicity levels in our
sample, as these villages are screened almost every year. When there is little variation in dv ðtÞ,
the true effects of variations might not become visible. These two fundamental vulnerabilities
may very well explain why (a function of) dv ðtÞ has not been identiﬁed as signiﬁcant for the
LMmodel. As a result, this model unrealistically predicts that the value of the expected preva-
lence level remains the same over time in the absence of screening activities, contrasting with
vast historical evidence.
The same vulnerabilities apply to the FEMmodel, which also provides a counter-intuitive
relation between the expected prevalence and dv ðtÞ. On top of that, its predictive power is rela-
tively low, which could be explained by the fact that, for many villages, there is insufﬁcient data
to estimate the ﬁxed effect accurately.
As variants of the logistic model already fix the structure of the relationship between dv ðtÞ
and fvðSvn þ dv ðtÞÞ based on epidemiological insights, these models do not suffer from the vul-
nerabilities mentioned above. We therefore consider these models to have most potential for
accurately predicting HAT prevalence levels in general (i.e., in any region and for any time
horizon). Among the three logistic model variants, model 3 (LMCCC) performs reasonably
well in terms of both criteria. Model 5 (LMVCC) has a substantial prediction bias, but performs
best in terms of explained variation, as can be seen in Fig 4 (its performance is closest to the
Fig 2. Evolution of the expected prevalence level over time for two villages according to the LMCCC
model (lines) versus the observed prevalence levels (circles and stars). Village 1: red solid line vs. red
circles. Village 2: blue dashed line vs. blue stars.
doi:10.1371/journal.pcbi.1005103.g002
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“perfect ﬁt”). Though model 4 (rLMCCC) performs best in terms of prediction bias, it per-
forms very weakly in terms of explained variation.
Hence, among the logistic model variants, there is no clear winner when both criteria are
assigned equal importance. For planning decisions, however, we consider model 5 to be most
suitable, followed by model 3. The reason is that, in contrast with prediction bias, explained
variation indicates the ability to identify differences in expected prevalence levels between vil-
lages, as required for effective planning decisions. Hence, identifying an effective prioritization
of the different villages will be more important than obtaining unbiased estimates of the result-
ing prevalence levels.
The sensitivity level s is known to differ between regions [35]. Furthermore, the population
size of a village had to be estimated, which induces a potential bias in the participation level
estimates. These issues beg to question the robustness of our results on the logistic model vari-
ants (note, models 1 and 2 are not affected by this as these do not use these parameters). S3
Table shows the results of a sensitivity analysis, which largely confirm our findings. In all sce-
nario’s analyzed, model 5 remains best in terms of explained variation, followed by model 3,
and models 3 and 4 outperform model 5 in terms of prediction bias. Another assumption that
questions the robustness of our results is the one about the expected prevalence level at the
Fig 3. Histogram of estimated carrying capacities for the 143 villages in Kwamouth, as estimated by
the LMCCCmodel.Measured as a percentage of the population.
doi:10.1371/journal.pcbi.1005103.g003
Table 2. Comparison of the predictive performance of the five models in terms of mean errors (ME),
mean absolute errors (MAE), andmean relative errors (MRE). The best indicator values are in bold.
ME MAE MRE
Model 1: LM −0.00186 0.00401 1.26
Model 2: FEM −0.00105 0.00507 1.60
Model 3: LMCCC −0.00094 0.00476 1.50
Model 4: rLMCCC 0.00047 0.00600 1.89
Model 5: LMVCC −0.00176 0.00363 1.14
doi:10.1371/journal.pcbi.1005103.t002
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beginning of the time horizon (i.e., at 01-01-2004). S4 Table provides the results of a sensitivity
analysis on this assumption. Again our main findings remain the same.
Analysis of the Fixed Frequency Screening Policy
In the previous section we argue that, among the models analyzed in this paper, variants of the
logistic model have most potential for accurately predicting HAT prevalence levels in general.
In this section we demonstrate the applicability of one of these model variants to analyze the
effectiveness of screening operations. In particular, since information on the development of
the carrying capacities is lacking, as required by the LMVCC model, and since we consider the
predictive performance of model 3 superior to that of model 4, we choose to use the LMCCC
model as a basis for this analysis. We do note that the theoretical results presented here also
hold for model 4 and, if the carrying capacity remains constant, for model 5 also.
Our analysis will concentrate on the fixed frequency screening policy. This policy assigns to
each village a fixed time interval for consecutive screening rounds based on the village’s charac-
teristics. As the policy is relatively easy to understand and implement, it has been the basis for
guideline documents for HAT control. For example, the WHO recommends a screening inter-
val of one year for villages reporting at least one case in the past three years, and an interval of
3 years for villages that did not report a case in the last three years, but did report at least one
case during the past five years [1].
In the first part of this section, we mathematically analyze the impact of a fixed screening
policy for a given village and investigate the screening frequency required to eradicateHAT in
that village. As mentioned in the introduction, we define that HAT is eradicated in the long
term if the expected prevalence level goes to zero in the long term.
A shorter term objective is to eliminate HAT, where elimination is defined as having at
most one new case per 10000 persons per year [1, 7]. For example, the WHO’s roadmap
towards elimination of HAT states the aim to eliminate (gambiense) HAT as a public health
problem by 2020—which is defined as having less than one new case per 10000 inhabitants in
Fig 4. Prediction errors (predicted prevalence—observed prevalence) for the 143 observations in the
prediction sample.
doi:10.1371/journal.pcbi.1005103.g004
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at least 90% of the disease foci [1]—and to reach worldwide elimination by 2030. The second
part of this section presents analytical results about the time needed to reach elimination and
about the screening frequency requirements for reaching elimination within a given time
frame. As our models consider expected prevalence instead of incidence, we redefine elimina-
tion as “reaching an expected prevalence level of one case per 10000”. We argue that the times
and efforts required to reach this elimination target are practically suitable lower bounds on
the times and efforts needed to reach the WHO’s targets. First, incidence and prevalence levels
are argued to be “comparable” for HAT if mobile units visit afflicted areas infrequently [16]. If
mobile teams visit the areas more frequently, incidence will only become larger compared to
prevalence and the prevalence level target will be easier to achieve than the incidence level tar-
get (e.g., under the assumption that the fraction of flies infected is proportional to the fraction
of humans infected, this follows directly from the epidemic model presented by Rogers [22]).
Second, even if the expected prevalence level is below the defined threshold level, the intrinsic
variability of the HAT epidemic may induce an actual prevalence level that exceeds this
threshold.
Throughout this section, we consider an imaginary village with a constant carrying capacity
K. (For sake of conciseness we omit the subscript v in this section). Furthermore, we assume a
constant participation level pvn = p, 0< p< 1, and a fixed screening interval τ. The expected
prevalence level at the beginning of the time horizon is denoted by f(0), f(0)> 0. Finally, recall
that s, 0< s< 1, denotes the sensitivity level.
Screening Requirements for Eradication. Let f n;nþ1 denote the expected average preva-
lence level faced between screening rounds n and n + 1. In S2 Text, we prove the following
results, which imply that the expected average HAT prevalence level will go to zero if the
screening interval τ is at most
 log ð1psÞ
k years, and that it will go to some strictly positive level
otherwise:
Proposition 1. If t   log ð1psÞk , then lim n!1f n;nþ1 ¼ 0.
Proposition 2. If t >  log ð1psÞk , then lim n!1
f n;nþ1 ¼ K log ð1psÞkt þ 1
 
.
A first insight provided by these propositions is that the eradication threshold for the
screening interval strongly depends on p and s: the level of participation in the screening activ-
ities and the sensitivity of the diagnostic test. To illustrate this, Fig 5 shows the screening inter-
val required for eradication for a range of values of the participation level and the sensitivity
level. For example, if both values equal 70%, the required screening interval is 0.84 years
(approximately once per 10 months). In case of participation and sensitivity levels of 99%, the
required interval equals 4.9 years. This reveals the tremendous benefits of maximizing these
values.
A second main insight is that annual screening, as currently recommended for endemic
areas [1], only leads to eradication if the case detection fraction—defined as participation times
sensitivity—exceeds 55%. For example, this is realized when the participation and sensitivity
levels are both at least 75%. Furthermore, under realistic current sensitivity and participation
levels—92.5% based on [4], and 70% based on our dataset, respectively—eradication requires a
screening frequency of at least once per 1.30 years (approximately 15 months).
A final insight is that the eradication threshold does not depend on the village’s carrying
capacity, meaning that the same upper bound on the screening frequency holds for all
endemic areas. This can be understood by observing that changing the carrying capacity
just changes the prevalence level with a constant factor at each point of time (see Eq (4)).
Consequently, also the long term average prevalence changes with this constant factor, and
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hence remains zero if and only if the eradication threshold is met. We note that this does
not imply that the disease burden, as measured by the number of person-years of illness,
does not depend on the village’s carrying capacity. In contrast, our results in S2 Text. reveal
that, for a given screening policy, the disease burden scales linearly with the carrying
capacity.
Screening Requirements for Elimination. Let a ¼ 1
1ps e
kt, b ¼ ps
1ps, and A0 ¼ Kf ð0Þ  1.
In S3 Text, we prove the following result on the time till the expected prevalence level hits a
predeﬁned level C in case of a screening interval of length τ:
Proposition 3. If f(0)> C and t   log ð1psÞk , the expected prevalence level is smaller than or
equal to C for the ﬁrst time after screening round n, where
n ¼
a log
K
C
 1þ b
a 1
A0 þ
b
a 1
0
B@
1
CA
2
6666
3
7777
if a > 1
K
C
 1 A0
b
2
6666
3
7777
if a ¼ 1
8>>>>><
>>>>>:
ð14Þ
This result enables us to estimate the time needed to reach the expected prevalence level of
1/10000 for a given village. For example, let us consider a “typical village” with a current long
Fig 5. Screening interval required to reach elimination, for different levels of participation in the
screening activities, and different levels of the sensitivity of the diagnostic test(s) performed.
doi:10.1371/journal.pcbi.1005103.g005
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term prevalence level (~x) of 5/1000 and let us assume that ~m ¼ 1 (the median historic screening
frequency in our dataset) and that f ð0Þ ¼ 0:5~x . Next, let us use the ﬁtted LMCCC model
described in Table 1 to estimate the village’s carrying capacity. Then, if annual screening is
maintained and under the estimated current sensitivity and participation levels, the estimated
time to elimination is 10 years.
Fig 6 provides some more insight into the relationship between the case detection fraction,
the screening interval and the number of years needed to reach elimination. We see that the
time to elimination ranges from 0.5 years (detection fraction: 99%, screening interval: 6
months) to 15 years (detection fraction: 75%, screening interval: 1.5 years) and that the detec-
tion fraction has a substantial impact on the time to elimination. For example, in case of a
screening interval of 1.5 years, the time to elimination decreases from 15 years to 4.5 years
when the case detection fraction increases from 75% to 90%. As explained, we consider the
times shown here to be lower bounds on the times needed to reach the WHO’s targets, which
is in line with earlier findings [10, 16].
Now, suppose that we would like to determine the screening interval needed to let the prev-
alence level cross the boundary C within T years. From the results stated in S2 Text. it follows
that this is equivalent to finding n: the smallest number of screening rounds such that
An  KC  1. Note that, under the ﬁxed frequency policy, performing n screening rounds in T
years implies a screening interval of T
n
years. In the following result, we assume that the ﬁrst
screening round is performed at time T
n
(and hence that the last is performed at time T):
Lemma 1. Given that t ¼ T
n
  log ð1psÞk , then limn !1 An =1 and the sequence {An} is
monotonically increasing in n.
Fig 6. Time needed to reach elimination in a “typical village” (current prevalence level of 5/1000), for
different levels of the case detection fraction (p  s) and different screening intervals.
doi:10.1371/journal.pcbi.1005103.g006
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This lemma justifies the use of a simple search algorithm for finding the number of screen-
ing rounds to perform in the next T years, given the target prevalence level C. For example, this
number can be found by increasing the value of n till An exceeds the threshold value KC  1.
We use this approach to determine the screening interval required to reach elimination
within 5 years from now for different levels of the case detection fraction and different current
long term prevalence levels (~x) of an imaginary village. Again, we use the ﬁtted LMCCC model
described in Table 1 for estimating the village’s carrying capacity and assume that ~m ¼ 1 and
that f ð0Þ ¼ 0:5~x .
Fig 7 depicts the results. We see that the number of screening rounds needed to reach elimi-
nation within five years ranges from 1 (i.e. τ = 5) to 11 (i.e. τ = 0.45). Another observation is
that annual screening only leads to elimination within five years if the case detection fraction is
very high—roughly above 75%—or if the current prevalence level is very low—roughly below
1/1000. For the reason stated before, we consider this to be a lower bound on the efforts needed
to reach the WHO’s targets within five years.
Discussion
This paper introduces and analyzes five models for predicting HAT prevalence in a given vil-
lage based on past observed prevalence levels and past screening activities in that village.
Based on the quality of prevalence level predictions in 143 villages in Kwamouth (DRC), and
Fig 7. Screening interval required to reach elimination within five years, for different levels of the case detection
fraction (p  s) and different current long term prevalence levels (~x).
doi:10.1371/journal.pcbi.1005103.g007
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based on the theoretical foundation underlying the models, we conclude that variants of the
logistic model—a model inspired by the SIS model—are most practically suitable for predict-
ing HAT prevalence levels. Sensitivity analyses show that this conclusion is very robust with
respect to assumptions about participation levels, the sensitivity of the diagnostic test, or the
initialization value of the prevalence curves are violated. Second, we demonstrate the applica-
bility of one variant of the logistic model to analyze the effectiveness of the fixed frequency
screening policy, which assigns to each village a fixed time interval for consecutive screening
rounds.
Due to the intrinsic variability of the HAT epidemic, observed prevalence levels will gener-
ally deviate significantly from predicted prevalence levels. We strongly believe, however, that
this does not render predictions worthless in the context of planning decisions. In contrast, a
major contribution of our models is that they indicate the expected disease burden in different
villages and can hence be applied to develop planning policies that aim to minimize the total
expected disease burden for the villages considered.
Our analysis of the fixed frequency screening policy reveals that eradication of HAT is to be
expected in the long term when the screening interval is smaller than a given threshold. This
threshold strongly depends on the case detection fraction: the fraction of cases who participate
in the screening rounds and are detected by the diagnostic tests. Under current conditions, we
estimate the threshold to be approximately 15 months. This suggests that annual screening, as
recommended by the WHO for endemic areas, will eventually lead to eradication. More specif-
ically, our model predicts that annual screening will lead to eradication if the case detection
fraction exceeds 55%.
The logistic model also reveals expressions for the time needed to reach the more short term
target of eliminating HAT and for the screening interval required to eliminate HAT within a
given time frame. These suggest that it takes 10 years to eliminate HAT in a village or focus
with a prevalence of 5/1000 (under current conditions and annual screening). Furthermore, we
estimate that it is only feasible to reach elimination within five years if the case detection frac-
tion is very high—roughly above 75%—or if the current prevalence level is very low—roughly
below 1/1000. We argue that these figures are practically suitable lower bounds on the time or
efforts needed to reach the WHO’s targets for elimination.
Our results on requirements for eradication or elimination are based on a deterministic
model, which begs to question their validity for reality, where events are stochastic. We note,
however, that we model the expected behavior of a stochastic system, and hence that our results
also hold in expectation for the stochastic system. On the other hand, we acknowledge that our
models are not perfect. For example, we neglect interaction effects between neighboring vil-
lages. It would therefore be interesting and relevant to investigate whether our results can be
reproduced by a validated simulation model.
A necessary condition for the applicability of our prediction models is that data about possi-
ble past HAT cases are available. Obviously, they thereby fail to identify endemic villages that
have never been visited by a screening team. Different types of models, making use of different
types of data—such as vegetation data (see e.g. [36]) or data about cases in nearby areas—are
needed for these villages. A second limitation of the models is that they have been tested on a
set of villages for which the screening interval was relatively short. Consequently, it is hard to
establish the behavior of the epidemic if much larger screening intervals are used or if screening
operations would be abandoned. Since datasets that do reveal this behavior are lacking, fitting
the models to an appropriate dataset obtained by a validated simulation model would be a
promising direction for future research.
We consider it likely that the speed of convergence to an epidemic equilibrium, as indicated
by the parameter κ, differs per disease focus. This may be due to differences in epidemiological
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conditions, such as the presence of an animal reservoir and the specific tsetse subspecies living
in a focus. These differences induce a need for developing and analyzing a cost-effective control
strategy that takes differences between foci into account, as also recognized by Simarro et al.
[37]. Repeating our analyses for different disease foci to investigate differences in requirements
for elimination and eradication would therefore be highly relevant.
Our analyses revealed that the effectiveness of screening operations strongly depends on the
participation level in the screening activities and the sensitivity of the diagnostic tests. Using
screening algorithms with a higher sensitivity or case finding procedures that increase partici-
pation levels therefore seems to be very effective. For example, Robays et al. [23] list several
combinations of diagnostic tests with different sensitivity levels, and a more acceptable case
finding procedure is currently being piloted in the DRC. Using our model to investigate the
cost-effectiveness of different control strategies, defining the screening frequencies as well as
the screening procedures and diagnostic tests used, would be a promising direction for future
research.
The results on the fixed frequency screening policy are all concerned with the screening fre-
quency or the time needed to reach certain targets. While at a strategic level, these results
might be interesting, at a tactical or operational level, screening frequency decisions are con-
strained by resource availability. Consequently, policies providing effective, acceptable, and
practically suitable recommendations on how to allocate available screening capacity over the
villages at risk are of much higher relevance at these levels. Literature about this allocation
problem is however absent, as also observed by the WHO [1], so that future research address-
ing this topic is much needed.
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